Calamos Advisors’s Forbion European Acquisition Corp. Warrants FRBNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-250,000
Closed -$138K 1020
2023
Q3
$138K Hold
250,000
﹤0.01% 759
2023
Q2
$111K Hold
250,000
﹤0.01% 798
2023
Q1
$35K Hold
250,000
﹤0.01% 957
2022
Q4
$36.2K Buy
+250,000
New +$35.6K ﹤0.01% 1003

Calamos Advisors's FRBNW Position: Q4 2023 in Review

Calamos Advisors sold out of Forbion European Acquisition Corp. Warrants (FRBNW) in Q4 2023, closing a stake of 250,000 shares — an estimated $138K sold.

Calamos Advisors first reported a position in FRBNW in Q4 2022 and held it in 4 quarters. The position peaked at $138K in Q3 2023. 0 funds tracked by Wall St. Rank hold FRBNW as of Q4 2023.

  • Calamos Advisors reported no remaining Forbion European Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Calamos Advisors sold 250,000 Forbion European Acquisition Corp. Warrants shares in Q4 2023, an estimated $138K.
  • Calamos Advisors first reported a position in Forbion European Acquisition Corp. Warrants in Q4 2022 and held it in 4 quarters.
  • Calamos Advisors's Forbion European Acquisition Corp. Warrants position peaked at $138K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Warrants as of Q4 2023.

Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.